Synopsis
India’s Education Ministry has stepped in to assist Malaysian students enrolled in PharmD programs in Egypt, addressing concerns over academic recognition and course alignment. The intervention aims to resolve regulatory gaps, ensure smooth progression of studies, and safeguard students’ professional qualification pathways.
The Malaysian Higher Education Ministry has stepped in to address a sensitive academic recognition issue involving four Malaysian students enrolled in a PharmD programme at Alexandria University in Egypt, after concerns emerged over the status of their qualification with the Pharmacy Board Malaysia (PBM). The ministry has assured that it is actively engaging with relevant authorities to ensure the affected students are not left in academic or professional uncertainty.
Higher Education Minister Datuk Seri Dr Zambry Abdul Kadir explained that the issue originated from a change in the programme’s naming structure by the Egyptian university. According to him, the course was previously offered under a broadly recognized pharmacy degree programme, which did not raise any concerns regarding its acceptance in Malaysia. However, when the university later restructured and renamed it as clinical pharmacy (PharmD), confusion arose over whether the updated qualification met the requirements set by Malaysian professional regulators.
Dr Zambry emphasized that the main issue stemmed from a lack of communication between the university and Malaysian regulatory bodies. He noted that institutions offering professional degrees such as pharmacy are expected to notify relevant authorities, including the Malaysian Qualifications Agency (MQA) and the Pharmacy Board Malaysia, before making significant changes to programme titles or structures. He stressed that pharmacy is a regulated profession, and recognition standards must align with professional accreditation frameworks governed by the Ministry of Health (MoH).
He further clarified that while the Higher Education Ministry plays a role in overseeing academic institutions and quality assurance through the MQA, the authority to recognize professional pharmacy qualifications lies specifically with the Pharmacy Board Malaysia, which operates under the Ministry of Health. As such, the recognition process cannot be unilaterally decided by the education ministry alone, highlighting the multi-agency nature of professional accreditation in Malaysia.
Despite the issue affecting only four Malaysian students, Dr Zambry expressed deep concern and assured that the government remains committed to supporting them. He stated that discussions have already been initiated with Health Minister Datuk Seri Dr Dzulkefly Ahmad to coordinate a joint solution between both ministries. The goal, he said, is to ensure that the students’ academic progress and future career pathways are not unfairly impacted due to administrative or recognition gaps.
Also Read: Egypt, UAE Push for Deeper Higher Education Cooperation
The minister also clarified that there is no dispute regarding the university’s general recognition under the Malaysian Qualifications Agency, which continues to acknowledge Alexandria University as a legitimate institution. The concern is specifically related to the updated PharmD programme structure, which differs from previously recognized pharmacy qualifications.
According to reports referenced from the New Straits Times, the Pharmacy Board Malaysia stated that it was not consulted regarding the introduction of the revised PharmD and PharmD (Clinical Pharmacy) programmes at Alexandria University. Historically, PBM had recognized earlier versions of pharmacy-related degrees from the institution, including the Bachelor of Pharmaceutical Science and Bachelor of Pharmacy (Clinical Pharmacy). However, those programmes were discontinued in 2019 and replaced with newer formats.
PBM further clarified that although Alexandria University currently offers updated pharmacy degrees, no formal application for recognition of these new programmes has been submitted to Malaysian authorities. As a result, the revised PharmD qualifications in Egypt have not yet been recognized under Malaysia’s Registration of Pharmacists Act 1951, creating uncertainty for students currently enrolled in the programme.
The issue came to light when at least four Malaysian students reportedly discovered, after nearly four years of study, that their degree might not be recognized for professional registration in Malaysia. This raised serious concerns about their future eligibility for internship requirements, licensing examinations, and eventual employment as registered pharmacists in the country.
The Malaysian government’s response to overseas education recognition issues underscores the importance of clear communication between international universities and national accreditation bodies. As discussions continue, authorities are working toward a resolution that balances regulatory compliance with fairness to students already committed to the programme, ensuring that their academic journey is not disrupted due to evolving programme classifications.